Table 1 Patient demographic and pre-transplant clinical characteristics for 7 US patients with non-Hodgkin or Hodgkin lymphoma undergoing autologous hematopoietic cell transplantation in 2020
|  | All (N = 7) |
|---|---|
Age at Transplant: Median (Range) | 63 (26–75) |
Sex | Â |
Male | 5 (41%) |
Female | 2 (29%) |
Disease | Â |
Non-Hodgkin’s Lymphoma | 6 (86%) |
Hodgkin’s Lymphoma | 1 (14%) |
Outcome | Â |
Alive | 7 (100%) |
CD34: Median (Range) | 3.9 (3.5–10.6) |
KPS: Median (Range) | 90 (80–90) |
HCT-CI Score Group | Â |
0 | 1 (14%) |
1–2 | 1 (14%) |
>2 | 5 (72%) |